Skip to main content
MedPathMedPath Home
Clinical Trials/JPRN-jRCTs062230014
JPRN-jRCTs062230014
Recruiting
Phase 2

Safety and efficacy of EUS-guided radiofrequency ablation for pancreatic neuroendocrine neoplasms: Pilot study

Matsumoto Kazuyuki0 sites5 target enrollmentMay 12, 2023
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
Matsumoto Kazuyuki
Enrollment
5
Status
Recruiting
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 12, 2023
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Matsumoto Kazuyuki

Eligibility Criteria

Inclusion Criteria

  • •1\. Age more than 18 years old
  • •2\. Patient who have been fully informed consent.
  • •3\. Pathologically confirmed PNEN with grade by EUS\-FNA (WHO 2017 classification)
  • •4\. Tumor size 15 mm or less on CE\-CT
  • •5\. non\-functionnal PNEN or insulinom

Exclusion Criteria

  • •1\. Allergy for contrast medium
  • •2\. Placement of a cardiac pacemaker
  • •3\. Within 2 mm of the distance between tumor and main pancreatic duct on radiographic images
  • •4\. Suspect of lymph node metastasis or distant metastasis on CE\-CT.
  • •5\. Less than 50% of PT or less than 1\.5 of INR
  • •6\. Less than 50,000/ L of PLT
  • •7\. Less than 30 mL/min of eGFR
  • •8\. Administeration of more than 2 antithrombotic
  • •9\. Not less than 2 of performance status
  • •10\. Being pregnant or possibly pregnant

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Efficacy of ultrasound-guided pulsed radiofrequency treatment on the saphenous nerve in knee osteoarthritis patients with refractory knee pain: A Randomized, double-blinded, pracebo-controlled trialrefractory knee pain in knee osteoarthritis
JPRN-UMIN000022736Osaka University Graduate School of Medicine100
Completed
Not Applicable
Efficacy and safety of the endoscopic radiofrequency ablation for unresectable cholangiocarcinoma: the pilot studycholangiocarcinoma
JPRN-UMIN000035394Sendai City Medical Center10
Recruiting
Not Applicable
Evaluation of Endoscopic Ultrasound-Guided Radiofrequency Ablation for the Management of Pancreatic Tumors, ERASE StudyPancreatic Neoplasm
NCT05961982Ohio State University Comprehensive Cancer Center84
Completed
Phase 2
Efficacy of ultrasound guided radiofrequency ablation of breast carcinomas <= 2cmbreast cancerbreast carcinoma1000629110006295
NL-OMON38082niversitair Medisch Centrum Utrecht24
Not yet recruiting
Phase 4
Safer technique among Ultrasound guided central line insertion versus blind technique.Health Condition 1: O- Medical and Surgical
CTRI/2024/01/061121MGM MEDICAL COLLEGE AND HOSPITA